When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Conifer Holdings
- The Trade: Elys Game Technology, Corp. (NASDAQ:ELYS) 10% owner Gold Street Capital Corp acquired a total of 28000 shares at an average price of $3.25. To acquire these shares, it cost $90,930.00.
- What’s Happening: Elys Game Technology, last month, reported record year-to-date betting handle of $626.9 million, up 77% year-over-year.
- What Elys Game Technology Does: Elys Game Technology Corp is a fastest growing and technologically advanced Sports Betting and i-Gaming full-service providers in the regulated business to business and business to consumer markets.
ADM Endeavors
- The Trade: ADM Endeavors, Inc. (OTC:ADMQ) CEO Marc Johnson acquired a total of 76000 shares at an average price of $0.08. The insider spent $5,982.10 to buy those shares.
- What’s Happening: The company’s stock dropped around 15% over the past month.
- What ADM Endeavors Does: Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.
PHX Minerals
- The Trade: PHX Minerals Inc. (NYSE:PHX) Director Glen A Brown acquired a total of 10000 shares at an average price of $2.35. To acquire these shares, it cost $10,002.47.
- What’s Happening: PHX Minerals reported a Q4 loss of $0.14 per share.
- What PHX Minerals Does: PHX Minerals, previously Panhandle Oil & Gas, is an oil and natural gas mineral company that has employed a strategy to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.
Silo Pharma
- The Trade: Silo Pharma, Inc. (OTC:SILO) CEO Eric Weisblum acquired a total of 22500 shares at an average price of $0.14. The insider spent $3,186.75 to buy those shares.
- What’s Happening: Silo Pharma engaged Donohoe Advisory to Assist with its efforts to obtain a listing on the NASDAQ Stock Market.
- What Silo Pharma Does: SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.
